Keywords: tlcgets, go-ahead, abelcet, liposome, company, been, granted

TLCGets US Go-Ahead For Abelcet

Article | 27 November 1995

Print This

The Liposome Company has been granted approval for Abelcet (amphotericin B lipid complex), for the treatment of aspergillosis in patients ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in